Natera (NTRA) - Management Comments

Natera (NTRA) – Management Comments

Jan 16, 2024 05:18 PM Natera (NTRA) Provides Update on Ravgen Trial
Mar 10, 2021 09:05 AM Natera (NTRA) and Genentech Begin Phase III Trial using Signatera as Companion Diagnostic for Atezolizumab in Early-Stage MIUC
Feb 25, 2021 05:44 PM
Jan 20, 2021 03:05 PM
Dec 3, 2020 09:03 AM
Dec 1, 2020 10:35 AM
Nov 30, 2020 09:58 AM
Nov 19, 2020 09:09 AM
Sep 1, 2020 09:09 AM
Aug 26, 2020 09:07 AM
Aug 3, 2020 11:21 AM
May 6, 2020 06:11 PM
Mar 3, 2020 09:06 AM
Feb 26, 2020 04:42 PM
Feb 11, 2020 09:06 AM
Dec 19, 2019 11:35 AM
Sep 13, 2019 11:52 AM
Aug 29, 2019 09:16 AM
May 6, 2019 11:56 AM
Mar 11, 2019 06:07 AM
Feb 22, 2019 09:03 AM
Jan 4, 2019 08:48 AM
Jan 2, 2019 04:06 PM
Nov 8, 2018 04:56 PM
Jul 31, 2018 11:06 AM
Jun 21, 2018 02:57 PM
Jun 13, 2018 08:17 AM
Apr 9, 2018 08:07 AM
Nov 6, 2017 08:18 AM
May 4, 2017 08:02 AM
Feb 3, 2017 08:00 AM
Dec 1, 2016 08:02 AM
Jun 30, 2016 01:37 PM